Las Vegas, NV -- (SBWIRE) -- 09/27/2013 -- PennyStockParlay.com Our process for picking penny stocks is not only unconventional, but untapped, undiscovered, and also exclusive. To keep our picks consistent with how only the "Best Penny Stocks" perform in the penny stock market, we have to keep our penny stock picks producing large and consistent gains.Have a look at today’s active stocks: -- U.S. Diana Shipping Inc.(NYSE:DSX), Astex Pharmaceuticals, Inc.(NASDAQ:ASTX), VIVUS, Inc.(NASDAQ:VVUS), BioCryst Pharmaceuticals, Inc.(NASDAQ:BCRX)
Diana Shipping Inc.(NYSE:DSX) reported the loss of -2.15% and closed at $12.31 with the total traded volume of 1.43M shares. Its market capitalization is $ 1.01 million. The stock has a 52-week high price of $13.24 and its 52-week low was recorded at $6.45
Diana Shipping Inc. is a holding company. The Company is a global provider of shipping transportation services.
What DSX Charts Are Signaling for Traders? Find Out Here
Astex Pharmaceuticals, Inc.(NASDAQ:ASTX) unchanged and ended at $8.51.The total traded volume was 1.42M shares and market capitalization arrived at $808.34 billion. The stock has a 52-week high price of $9.39 and its 52-week low was recorded at $2.14, while during last trade its minimum price was $8.49 and it gained the highest price of $8.55.
Astex Pharmaceuticals, Inc. engages in the discovery and development of small molecule therapeutics with a focus on oncology and hematology using its fragment-based drug discovery platform, Pyramid.
Is ASTX Buy After The Recent Price Movement? Find Out Here
VIVUS, Inc.(NASDAQ:VVUS)’s reported gain 1.35% close at $9.77 with the overall traded volume of 1.41M shares. Its market capitalization on last close reached to $985.33 million. The company has the total of 100.85 million outstanding shares. Its intraday-low price was $9.50 and its hit its day's highest price at $9.90.
VIVUS, Inc. is a biopharmaceutical company. It commercializes and develops therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health.
Should VVUS a Buy or Sell Now? Find Out Here
BioCryst Pharmaceuticals, Inc.(NASDAQ:BCRX) increase 3.43% settle at $7.24. Its total traded volume during last trading session was 1.41M shares. The overall market worth of this company is about $421.74 million. The 52 week range of the stock remained $1.08 - $7.41, while its day's lowest price was $6.96 and its hit its day's highest price at $7.25.
BioCryst Pharmaceuticals, Inc. (BioCryst) is a biotechnology company. BioCryst designs, optimizes and develops drugs that block enzymes involved in the pathogenesis of diseases.
What BCRX Charts Are Signaling for Traders? Find Out Here
Penny stocks are stocks that can be traded in the stock market at a very cheap price. The investor who decides to buy penny stocks should have a substantial intellect of the market and should be bequeathing to possibly suffer a loss in money. The phrase penny stock is usually used for stock dealing that does not imply the greater and popularly known exchanges.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the PennyStockParlay.comnewsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
PennyStockParlay.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your investment manager before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies in the profiled on the PennyStockParlay.com web site and/or newsletter involve a high degree of risk and volatility, and all investors should know that they may lose a portion or all of their investment if they decide to purchase any stock.
Read Full Disclaimer at: http://pennystockparlay.com/disclaimer.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)